Evolution of serious and life-threatening COVID-19 pneumonia as the SARS-CoV-2 pandemic progressed: an observational study of mortality to 60 days after admission to a 15-hospital US health system.
Sudish C MurthySteven M GordonAshley M LowryEugene H BlackstonePublished in: BMJ open (2024)
Hospital mortality from COVID-19 decreased substantially as the pandemic evolved but persisted after hospital discharge, eclipsing hospital mortality by 50% or more. However, after accounting for the many, even subtle, changes across the pandemic in patients' demographics, medical history and particularly admission laboratory results, a patient admitted early in the pandemic and predicted to be at high risk would remain at high risk of mortality if admitted tomorrow.
Keyphrases
- sars cov
- coronavirus disease
- respiratory syndrome coronavirus
- cardiovascular events
- healthcare
- risk factors
- emergency department
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- type diabetes
- adverse drug
- cardiovascular disease
- coronary artery disease
- case report
- prognostic factors
- patient reported outcomes
- acute respiratory distress syndrome